Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Tacrolimus capsules, used as immuno-suppressant. The approved product is a generic version of Prograf Capsules of Astellas Pharm US, Inc. Tacrolimus capsule is an immunosuppressant and is used for preventing organ rejection in certain patients following liver, kidney, or heart transplant.from IndiaTV India: Google News Feed https://ift.tt/38uMdfE
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.